|
PGRMC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.638900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.363000E-03 |
| Normal-vs-Stage2 |
3.067900E-02 |
| Normal-vs-Stage3 |
3.576400E-04 |
| Normal-vs-Stage4 |
7.89500000000221E-05 |
| Stage1-vs-Stage2 |
5.639200E-01 |
| Stage1-vs-Stage3 |
1.425410E-01 |
| Stage1-vs-Stage4 |
4.004200E-02 |
| Stage2-vs-Stage3 |
7.595000E-01 |
| Stage2-vs-Stage4 |
4.242200E-01 |
| Stage3-vs-Stage4 |
4.600400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.633400E-04 |
| Normal-vs-AfricanAmerican |
6.670600E-01 |
| Normal-vs-Asian |
2.018100E-02 |
| Caucasian-vs-AfricanAmerican |
1.451050E-01 |
| Caucasian-vs-Asian |
7.758400E-01 |
| AfricanAmerican-vs-Asian |
2.466000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.613100E-04 |
| Normal-vs-Female |
9.203800E-04 |
| Male-vs-Female |
4.224800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.657500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.415970E-03 |
| Normal-vs-Age(61-80Yrs) |
2.81629999998589E-06 |
| Normal-vs-Age(81-100Yrs) |
1.684420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.544650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.019400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.708800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.367700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.383600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.470200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.102400E-02 |
| Classical-VS-Follicular |
7.61930000000577E-05 |
| Classical-VS-Other |
8.762400E-01 |
| Classical-VS-Normal |
2.746400E-02 |
| Tall-VS-Follicular |
2.642600E-01 |
| Tall-VS-Other |
5.578600E-01 |
| Tall-VS-Normal |
2.261300E-03 |
| Follicular-VS-Other |
3.594400E-01 |
| Follicular-VS-Normal |
1.68089999996734E-06 |
| Other-VS-Normal |
7.562000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.822800E-04 |
| Normal-vs-N1 |
2.624100E-04 |
| N0-vs-N1 |
4.529400E-01 |
|
|
